Please note that letters and emails to the editor should be no more than 500 words with a maximum of five references.Re: Antenatal venous thromboembolism Dear Editor, I was very interested in the article on antenatal venous thromboembolism 1 published in The Obstetrician & Gynaecologist (TOG) in Volume 23 Issue 3 and would like to complement the authors on the well-written article.While reading the same, I stumbled upon a discrepancy between the article and the Green-top Guideline No. 37b on Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management, 2 regarding the management of suspected deep vein thrombosis (DVT) in pregnant patients. This aforementioned TOG article, on page 207, under the paragraph with the sub-heading 'Deep vein thrombosis' in the sixth sentence (eighth line) mentions, "However, if there is a persistent clinical suspicion, RCOG guidance recommends that treatment should be continued and ultrasound repeated 3 and 7 days later." Upon reviewing the Green-top Guideline, the recommendation on page 2 of 32 under the question, "What investigations are needed for the diagnosis of an acute DVT?" states in the second paragraph under the above question "If ultrasound is negative and there is a low level of clinical suspicion, anticoagulant treatment can be discontinued." It continues to recommend further action on an ultrasound that is negative as follows: "If ultrasound is negative and a high level of clinical suspicion exists, anticoagulant treatment should be discontinued but the ultrasound should be repeated on days 3 and 7. [New 2015]".I would like to draw the attention of the authors to this discrepancy and would appreciate clarification on this, enabling the readers to take home a clear message. Along the journey of continued learning and reflecting, I would also like to learn if I have possibly made an error in reading or understanding the intended guidance or the article. Though I agree with the authors that if there exists a strong clinical suspicion, continuing the anticoagulant treatment makes a lot more sense; but I then question what the repeat tests on day 3 and 7 may show, as they may cause possible resolution of any thrombosis that may have been there.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.